Regenerative Medical Technology (RMTG) Prepaid Assets (2017 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Prepaid Assets of $171253.0 for Q1 2026, down 8.6% year-over-year from $187364.0 in Q1 2025, and up 172.05% quarter-over-quarter from $62950.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Prepaid Assets (2017 - 2026) Analysis & Trends
Regenerative Medical Technology's Prepaid Assets history runs 8 years deep, the most recent figure standing at $171253.0 for Q1 2026.
- In Q1 2026, Prepaid Assets fell 8.6% year-over-year to $171253.0; the TTM figure through Mar 2026 stood at $171253.0 (down 8.6% YoY), while the FY2025 annual figure was $62950.0, up 26.7% from the prior year.
- Prepaid Assets for Q1 2026 stood at $171253.0, up from $62950.0 in the prior quarter.
- The five-year high for Prepaid Assets was $187364.0 in Q1 2025, with the low at $10750.0 in Q3 2023.
- The 5-year median for Prepaid Assets is $52274.5 (2024), against an average of $80061.6.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets sank 30.67% in 2022, then soared 311.79% in 2025.
- Regenerative Medical Technology's Prepaid Assets stood at $121332.0 in 2022, then slumped by 83.1% to $20500.0 in 2023, then soared by 142.37% to $49685.0 in 2024, then advanced by 26.7% to $62950.0 in 2025, then surged by 172.05% to $171253.0 in 2026.
- Business Quant data shows RMTG's Prepaid Assets at $171253.0 in Q1 2026, $62950.0 in Q4 2025, and $54864.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171,253.00 |
| Dec 31, 2025 | 62,950.00 |
| Sep 30, 2025 | 54,864.00 |
| Jun 30, 2025 | 154,864.00 |
| Mar 31, 2025 | 187,364.00 |
| Dec 31, 2024 | 49,685.00 |
| Sep 30, 2024 | 43,067.00 |
| Jun 30, 2024 | 38,610.00 |
| Mar 31, 2024 | 45,500.00 |
| Dec 31, 2023 | 20,500.00 |
| Sep 30, 2023 | 10,750.00 |
| Mar 31, 2022 | 121,332.00 |
| Dec 31, 2021 | 24,245.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 175,000.00 |
| Mar 31, 2021 | 175,000.00 |
| Dec 31, 2020 | 175,000.00 |
| Sep 30, 2020 | 175,000.00 |
| Jun 30, 2020 | 50,000.00 |
| Dec 31, 2017 | 109.00 |